+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biopsy Forceps Market by Product Type, Application, End User, Distribution Channel - Global Forecast to 2030- Product Image
Biopsy Forceps Market by Product Type, Application, End User, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Biopsy Forceps Market by Product Type, Application, End User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6083678
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biopsy Forceps Market grew from USD 221.93 million in 2024 to USD 234.78 million in 2025. It is expected to continue growing at a CAGR of 5.63%, reaching USD 308.31 million by 2030.

Navigating the Critical Role of Biopsy Forceps in Modern Diagnostic Care

The biopsy forceps market has become a cornerstone of modern diagnostic and interventional procedures, enabling clinicians to obtain accurate tissue samples across a spectrum of medical specialties. From gastrointestinal assessments to advanced bronchoscopy and gynecological applications, these precision instruments facilitate early detection and informed treatment decisions. The evolution of forceps design, sterilization protocols, and materials science has elevated procedural safety and patient outcomes. Recent years have witnessed a heightened emphasis on minimizing cross-contamination through the adoption of single-use solutions, while innovations in reusable forceps continue to offer cost efficiencies and environmental benefits.

Against this backdrop of rapid technological advancement and shifting regulatory priorities, this executive summary distills critical insights shaping the global market. Drawing on the latest industry data, policy developments, and stakeholder interviews, the analysis highlights emerging opportunities and challenges. Readers will gain a foundational understanding of the current market dynamics, as well as a framework for interpreting the forces that will influence adoption, procurement, and competitive positioning. By situating key trends within the broader healthcare ecosystem, this introduction sets the stage for a deeper examination of transformative market shifts, trade policy impacts, segmentation themes, regional variations, and strategic imperatives for industry participants.

Emerging Innovations and Paradigm Shifts Reshaping the Biopsy Forceps Market

The biopsy forceps landscape is undergoing transformative change driven by technological breakthroughs and evolving clinical demands. The integration of digital imaging and miniaturized optics within forceps assemblies has enabled more precise targeting of lesions, thereby enhancing diagnostic yield and reducing procedure durations. Concurrently, the rise of single-use devices has shifted procurement strategies, as healthcare providers weigh the benefits of infection control against environmental considerations and per-procedure costs. Advances in materials science, including the use of advanced polymers and lightweight alloys, have improved maneuverability and tactile feedback, opening new frontiers in minimally invasive procedures.

Regulatory frameworks are also adapting, with increased scrutiny on sterilization methods for reusable instruments and accelerated pathways for single-use product approvals. Moreover, sustainability imperatives are prompting manufacturers to explore eco-friendly packaging and end-of-life recycling programs. In parallel, strategic consolidation among key suppliers and partnerships with technology developers are reshaping the competitive landscape. These paradigm shifts collectively underscore a market in flux, where innovation and regulatory alignment converge to redefine the procurement and utilization of biopsy forceps across diverse clinical settings.

Assessing the 2025 U.S. Tariffs and Their Ripple Effect on Biopsy Forceps Dynamics

The implementation of new United States tariffs in 2025 has introduced significant cost pressures across the biopsy forceps supply chain. With increased import duties targeting a range of medical device categories, manufacturers face higher material and component costs, which in turn influence pricing strategies and profit margins. Procurement departments at hospitals and ambulatory surgical centers are recalibrating vendor agreements and evaluating domestic sourcing options to mitigate these financial impacts. The combined effect of tariff pass-through and currency fluctuations has led some suppliers to explore alternative manufacturing hubs and regional assembly centers to preserve price competitiveness.

Furthermore, the tariffs have prompted a renewed focus on value-based procurement, as healthcare systems strive to balance cost containment with clinical efficacy. Collaborative agreements between device producers and providers are emerging, emphasizing volume-based discounts, risk-sharing arrangements, and consignment models. As a result, manufacturers are investing in localized production capabilities and supply chain resilience to navigate trade policy volatility. These strategic adjustments underscore the importance of agility and partnerships in sustaining market growth amid evolving tariff structures and geopolitical dynamics.

Unveiling Market Segmentation Patterns That Define Biopsy Forceps Demand

In exploring demand drivers, product type segmentation reveals a clear dichotomy: reusable forceps retain favor in high-volume facilities where autoclavable and chemical sterilization protocols deliver long-term cost benefits, while the rise of single-use devices-both non-sterile and sterile variants-reflects a prioritization of infection control and regulatory compliance. Applications extend beyond traditional gastroenterology and bronchoscopy to encompass a spectrum that includes gynecological and urological procedures. Within bronchoscopy, conventional techniques coexist with endobronchial ultrasound platforms, while gastrointestinal endoscopy spans both colonoscopy and esophagogastroduodenoscopy, each presenting unique forceps requirements.

The spectrum of end users ranges from ambulatory surgical centers optimizing throughput for routine interventions to specialized clinics focusing on niche procedures, and large hospitals managing complex surgical portfolios. Distribution strategies likewise vary: long-established distributor networks continue to serve many providers, whereas direct hospital procurement channels increasingly streamline bulk purchasing. Simultaneously, online retail platforms are gaining traction, offering expedited ordering and transparency in pricing. These segmentation dimensions collectively illustrate a market characterized by diverse clinical demands, logistical considerations, and procurement preferences across multiple stakeholder groups.

Analyzing Regional Market Drivers Across the Americas, EMEA, and Asia-Pacific

Regional dynamics play a pivotal role in shaping market trajectories. In the Americas, advanced healthcare infrastructure and robust reimbursement models drive steady adoption of high-end reusable and single-use forceps, with major metropolitan hospitals leading volume procurement. Europe, the Middle East & Africa present a heterogeneous landscape: mature European markets emphasize regulatory conformity and sustainability, while Middle Eastern healthcare modernization initiatives fuel investment in cutting-edge endoscopy suites. In Africa, demand remains nascent but shows promise as public and private partnerships expand access to diagnostic technologies.

Asia-Pacific emerges as a high-growth region, propelled by expanding healthcare budgets, a rising incidence of chronic diseases, and an increasing number of minimally invasive procedures. Governments across Asia-Pacific are investing in healthcare infrastructure, which accelerates the adoption of both reusable and disposables in urban centers. The interplay between regional procurement norms and local manufacturing efforts further shapes competitive dynamics. Taken together, these geographic variations underscore the necessity for tailored market strategies that align product portfolios, regulatory compliance, and distribution models with specific regional priorities.

Strategies and Competitive Moves from Leading Biopsy Forceps Manufacturers

Leading manufacturers are pursuing differentiated strategies to solidify their market positions. Some have intensified R&D investments in polymer-based single-use forceps that deliver consistent performance while reducing cross-contamination risks. Others have forged alliances with digital health companies to integrate guided imaging technologies directly into forceps handles, enhancing procedural accuracy. Strategic acquisitions have also emerged as a critical tactic, enabling companies to broaden their product portfolios, gain access to new distribution channels, and leverage established customer relationships.

Moreover, a subset of industry players is capitalizing on service-based offerings, such as sterilization support programs and device management platforms that streamline inventory control for hospitals. These value-added services not only generate recurring revenue streams but also foster deeper customer engagement. Competitive advantage increasingly hinges on multi-faceted approaches that combine product innovation, strategic partnerships, and service differentiation to address evolving clinical and operational needs.

Strategic Imperatives for Industry Leaders to Stay Ahead in Biopsy Forceps

To remain at the forefront, industry leaders should prioritize investment in advanced materials research aimed at enhancing both single-use and reusable forceps durability and tactile performance. Establishing collaborative ventures with healthcare providers will enable co-development of instruments tailored to specific procedural workflows, ensuring seamless integration into clinical practice. Additionally, diversifying manufacturing footprints to include near-shore or local production hubs can mitigate trade policy risks and optimize supply chain agility.

Active engagement with regulatory agencies will facilitate early alignment on sterilization standards and environmental protocols, positioning organizations as trusted partners in sustainable healthcare delivery. Finally, embracing digital channels for both product distribution and post-market surveillance can streamline procurement processes and yield real-time feedback, driving continuous product refinement and strengthening customer loyalty.

Robust Research Framework Underpinning Biopsy Forceps Market Insights

This analysis draws upon a rigorous research framework combining primary interviews with senior medical device executives, procurement leaders, and clinical end users. Secondary data sources including regulatory filings, company reports, and peer-reviewed publications were synthesized to ensure comprehensive coverage of technological, regulatory, and commercial developments. Market segmentation and regional analyses were validated through triangulation of shipment data, financial disclosures, and end-user surveys.

Throughout the study, methodological rigor was maintained by cross-referencing qualitative insights with quantitative indicators to minimize bias and enhance data reliability. The resulting insights reflect a balanced perspective that integrates diverse stakeholder viewpoints, enabling robust guidance for both established incumbents and emerging challengers.

Synthesis of Key Findings Highlighting Future Directions for Biopsy Forceps

In summary, the biopsy forceps market stands at an inflection point marked by technological innovation, regulatory evolution, and shifting procurement paradigms. While reusable instruments continue to offer cost efficiencies for high-volume settings, the rapid uptake of single-use forceps underscores a broader commitment to patient safety and infection control. Tariff-induced cost pressures have catalyzed supply chain resilience measures, prompting manufacturers to explore localized production and strategic partnerships.

Consumers and providers alike are navigating an increasingly complex landscape defined by diverse segmentation dynamics and region-specific demands. Manufacturers that adeptly align their product development, distribution strategies, and service offerings with these multifaceted factors will secure a sustained competitive edge. The insights presented herein offer a strategic roadmap for stakeholders seeking to capitalize on emerging opportunities and effectively address the challenges ahead.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Reusable
      • Autoclavable
      • Chemical Sterilization
    • Single Use
      • Non Sterile
      • Sterile
  • Application
    • Bronchoscopy
      • Conventional
      • Endobronchial Ultrasound
    • Gastrointestinal Endoscopy
      • Colonoscopy
      • Esophagogastroduodenoscopy
    • Gynecology
    • Urology
  • End User
    • Ambulatory Surgical Centers
    • Clinics
    • Hospitals
  • Distribution Channel
    • Distributors
    • Hospital Procurement
    • Online Retail
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Olympus Corporation
  • Boston Scientific Corporation
  • Medtronic plc
  • Cook Medical LLC
  • KARL STORZ SE & Co. KG
  • HOYA Corporation
  • Fujifilm Holdings Corporation
  • CONMED Corporation
  • STERIS plc
  • Ambu A/S

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biopsy Forceps Market, by Product Type
8.1. Introduction
8.2. Reusable
8.2.1. Autoclavable
8.2.2. Chemical Sterilization
8.3. Single Use
8.3.1. Non Sterile
8.3.2. Sterile
9. Biopsy Forceps Market, by Application
9.1. Introduction
9.2. Bronchoscopy
9.2.1. Conventional
9.2.2. Endobronchial Ultrasound
9.3. Gastrointestinal Endoscopy
9.3.1. Colonoscopy
9.3.2. Esophagogastroduodenoscopy
9.4. Gynecology
9.5. Urology
10. Biopsy Forceps Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Clinics
10.4. Hospitals
11. Biopsy Forceps Market, by Distribution Channel
11.1. Introduction
11.2. Distributors
11.3. Hospital Procurement
11.4. Online Retail
12. Americas Biopsy Forceps Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Biopsy Forceps Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Biopsy Forceps Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Olympus Corporation
15.3.2. Boston Scientific Corporation
15.3.3. Medtronic plc
15.3.4. Cook Medical LLC
15.3.5. KARL STORZ SE & Co. KG
15.3.6. HOYA Corporation
15.3.7. Fujifilm Holdings Corporation
15.3.8. CONMED Corporation
15.3.9. STERIS plc
15.3.10. Ambu A/S
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BIOPSY FORCEPS MARKET MULTI-CURRENCY
FIGURE 2. BIOPSY FORCEPS MARKET MULTI-LANGUAGE
FIGURE 3. BIOPSY FORCEPS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOPSY FORCEPS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BIOPSY FORCEPS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BIOPSY FORCEPS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BIOPSY FORCEPS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BIOPSY FORCEPS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOPSY FORCEPS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOPSY FORCEPS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY AUTOCLAVABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY CHEMICAL STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY NON STERILE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY STERILE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY ENDOBRONCHIAL ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY COLONOSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY ESOPHAGOGASTRODUODENOSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY GYNECOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY UROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY HOSPITAL PROCUREMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES BIOPSY FORCEPS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 52. CANADA BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 53. CANADA BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 54. CANADA BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 55. CANADA BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. CANADA BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 57. CANADA BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 58. CANADA BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. CANADA BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. MEXICO BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 61. MEXICO BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 62. MEXICO BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 63. MEXICO BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. MEXICO BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 65. MEXICO BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 66. MEXICO BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. MEXICO BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 93. UNITED KINGDOM BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. UNITED KINGDOM BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. GERMANY BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 102. GERMANY BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 103. GERMANY BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 104. GERMANY BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. GERMANY BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 106. GERMANY BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 107. GERMANY BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. GERMANY BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. FRANCE BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 110. FRANCE BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 111. FRANCE BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 112. FRANCE BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. FRANCE BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 114. FRANCE BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 115. FRANCE BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. FRANCE BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. ITALY BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. ITALY BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 127. ITALY BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 128. ITALY BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. ITALY BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 130. ITALY BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 131. ITALY BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. ITALY BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. SPAIN BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 134. SPAIN BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 135. SPAIN BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 136. SPAIN BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. SPAIN BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 138. SPAIN BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 139. SPAIN BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. SPAIN BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 149. SAUDI ARABIA BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 150. SAUDI ARABIA BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 151. SAUDI ARABIA BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 152. SAUDI ARABIA BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. SAUDI ARABIA BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. SOUTH AFRICA BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 158. SOUTH AFRICA BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. DENMARK BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 166. DENMARK BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 167. DENMARK BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 168. DENMARK BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. DENMARK BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 170. DENMARK BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 171. DENMARK BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. DENMARK BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. NETHERLANDS BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 174. NETHERLANDS BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 175. NETHERLANDS BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. QATAR BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 182. QATAR BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 183. QATAR BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 184. QATAR BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. QATAR BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 186. QATAR BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 187. QATAR BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. QATAR BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. FINLAND BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 190. FINLAND BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 191. FINLAND BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 192. FINLAND BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. FINLAND BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 194. FINLAND BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 195. FINLAND BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. FINLAND BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. SWEDEN BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 198. SWEDEN BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 199. SWEDEN BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 200. SWEDEN BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. SWEDEN BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 202. SWEDEN BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. EGYPT BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 214. EGYPT BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 215. EGYPT BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 216. EGYPT BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. EGYPT BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 218. EGYPT BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 219. EGYPT BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. EGYPT BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 221. TURKEY BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 222. TURKEY BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 223. TURKEY BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 224. TURKEY BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. TURKEY BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 226. TURKEY BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 227. TURKEY BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. TURKEY BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. ISRAEL BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 230. ISRAEL BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 231. ISRAEL BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 232. ISRAEL BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. ISRAEL BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 234. ISRAEL BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 237. NORWAY BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 238. NORWAY BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 239. NORWAY BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 240. NORWAY BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. NORWAY BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 242. NORWAY BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 243. NORWAY BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. NORWAY BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 245. POLAND BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 246. POLAND BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 247. POLAND BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 248. POLAND BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. POLAND BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 250. POLAND BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 251. POLAND BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. POLAND BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 253. SWITZERLAND BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. SWITZERLAND BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 261. ASIA-PACIFIC BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 262. ASIA-PACIFIC BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 270. CHINA BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 271. CHINA BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 272. CHINA BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 273. CHINA BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. CHINA BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 275. CHINA BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 276. CHINA BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. CHINA BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 278. INDIA BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 279. INDIA BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 280. INDIA BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 281. INDIA BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 282. INDIA BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 283. INDIA BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 284. INDIA BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. INDIA BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 286. JAPAN BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 287. JAPAN BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 288. JAPAN BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 289. JAPAN BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 290. JAPAN BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 291. JAPAN BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 292. JAPAN BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 293. JAPAN BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 294. AUSTRALIA BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 295. AUSTRALIA BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 296. AUSTRALIA BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 297. AUSTRALIA BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 298. AUSTRALIA BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 302. SOUTH KOREA BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 303. SOUTH KOREA BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 304. SOUTH KOREA BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 305. SOUTH KOREA BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 306. SOUTH KOREA BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 310. INDONESIA BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 311. INDONESIA BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 312. INDONESIA BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 313. INDONESIA BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 314. INDONESIA BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 315. INDONESIA BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 318. THAILAND BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 319. THAILAND BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 320. THAILAND BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 321. THAILAND BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 322. THAILAND BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 323. THAILAND BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 324. THAILAND BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 325. THAILAND BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 326. PHILIPPINES BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 327. PHILIPPINES BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 328. PHILIPPINES BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 329. PHILIPPINES BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 330. PHILIPPINES BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 331. PHILIPPINES BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 332. PHILIPPINES BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 333. PHILIPPINES BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 334. MALAYSIA BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 335. MALAYSIA BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 336. MALAYSIA BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 337. MALAYSIA BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 338. MALAYSIA BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 339. MALAYSIA BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 340. MALAYSIA BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 341. MALAYSIA BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 342. SINGAPORE BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 343. SINGAPORE BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 344. SINGAPORE BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 345. SINGAPORE BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 346. SINGAPORE BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 347. SINGAPORE BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 348. SINGAPORE BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 349. SINGAPORE BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 350. VIETNAM BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 351. VIETNAM BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 352. VIETNAM BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 353. VIETNAM BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 354. VIETNAM BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2030 (USD MILLION)
TABLE 355. VIETNAM BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2030 (USD MILLION)
TABLE 356. VIETNAM BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 357. VIETNAM BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 358. TAIWAN BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 359. TAIWAN BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2030 (USD MILLION)
TABLE 360. TAIWAN BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2030 (USD MILLION)
TABLE 361. TAIWAN BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2030 (US

Companies Mentioned

The companies profiled in this Biopsy Forceps market report include:
  • Olympus Corporation
  • Boston Scientific Corporation
  • Medtronic plc
  • Cook Medical LLC
  • KARL STORZ SE & Co. KG
  • HOYA Corporation
  • Fujifilm Holdings Corporation
  • CONMED Corporation
  • STERIS plc
  • Ambu A/S

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages183
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 234.78 Million
Forecasted Market Value ( USD ) by 2030 $ 308.31 Million
Compound Annual Growth Rate5.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Disposable Foreign Body Forceps Market by Product Type, End User, Distribution Channel, Material, Application - Global Forecast to 2030 - Product Image

Disposable Foreign Body Forceps Market by Product Type, End User, Distribution Channel, Material, Application - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
Biopsy Forcep Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application - Product Image

Biopsy Forcep Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application

  • Report
  • 96 Pages
  • Global
From
Biopsy Forceps - Global Strategic Business Report - Product Image

Biopsy Forceps - Global Strategic Business Report

  • Report
  • 92 Pages
  • Global
From
Prostate Biopsy Forcep Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Prostate Biopsy Forcep Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 84 Pages
  • Global
From
Biopsy Devices Market Size, Share & Trends Analysis Report By Product (Needle-based Biopsy Guns, Biopsy Guidance Systems, Biopsy Forceps, Biopsy Needles), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Biopsy Devices Market Size, Share & Trends Analysis Report By Product (Needle-based Biopsy Guns, Biopsy Guidance Systems, Biopsy Forceps, Biopsy Needles), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From

About the Biopsy Forceps Market

In the domain of surgical devices, biopsy forceps constitute a crucial category of instruments designed primarily for the procurement of tissue samples for pathological examination. These forceps come in various shapes and sizes, tailored to the specific requirements of different biopsy procedures. They are frequently utilized across a range of medical specialties, including gastroenterology, gynecology, and urology. Biopsy forceps are designed to operate within the constraints of minimally invasive techniques, often being a part of endoscopic or laparoscopic equipment. Their construction allows for precision handling and control, securing an adequate tissue sample while minimizing patient discomfort and potential complications. These instruments can be classified into numerous subtypes, such as cupped, oval, or fenestrated, each catering to the nuances of different tissue types and locations. Also, they are available in both disposable and reusable forms, with the former aiding in the prevention of cross-contamination between procedures. As an integral component of surgical devices, the biopsy forceps market is characterized by innovation and technological advancement, focusing on enhancing the accuracy of diagnostics and the overall safety of surgical procedures. Prominent companies involved in the manufacture and distribution of biopsy forceps include Olympus Corporation, Boston Scientific, Cook Medical, Medtronic, and Steris. These entities are known for their engagement in the development, production, and marketing of medical-grade biopsy instruments and continue to influence the course of the market through their contributions to the field. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.